AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 29 filers reported holding AIM IMMUNOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,979 | -32.1% | 707,646 | +0.0% | 0.00% | – |
| Q2 2023 | $474,054 | +34.9% | 707,544 | -13.4% | 0.00% | – |
| Q1 2023 | $351,365 | +38.4% | 817,127 | +0.4% | 0.00% | – |
| Q4 2022 | $253,801 | -46.3% | 813,726 | +0.0% | 0.00% | – |
| Q3 2022 | $473,000 | -25.9% | 813,460 | -0.4% | 0.00% | – |
| Q2 2022 | $638,000 | -27.3% | 816,702 | -1.4% | 0.00% | – |
| Q1 2022 | $878,000 | +14.5% | 828,543 | -0.7% | 0.00% | – |
| Q4 2021 | $767,000 | -54.2% | 834,303 | +0.7% | 0.00% | – |
| Q3 2021 | $1,673,000 | -5.4% | 828,158 | +0.7% | 0.00% | – |
| Q2 2021 | $1,769,000 | -20.4% | 822,690 | -16.0% | 0.00% | – |
| Q1 2021 | $2,223,000 | +143.2% | 979,042 | +91.7% | 0.00% | – |
| Q4 2020 | $914,000 | -15.4% | 510,796 | +1.6% | 0.00% | – |
| Q3 2020 | $1,080,000 | -8.5% | 502,692 | +5.7% | 0.00% | – |
| Q2 2020 | $1,180,000 | +4270.4% | 475,602 | +4418.8% | 0.00% | – |
| Q1 2020 | $27,000 | +350.0% | 10,525 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -25.0% | 10,525 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | – | 10,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ForthRight Wealth Management, LLC | 20,000 | $13,400 | 0.01% |
| SeaCrest Wealth Management, LLC | 37,063 | $24,832 | 0.00% |
| D.B. Root & Company, LLC | 12,050 | $8,074 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 108,900 | $72,963 | 0.00% |
| Traynor Capital Management, Inc. | 11,777 | $7,891 | 0.00% |
| Community Bank, N.A. | 13,226 | $8,861 | 0.00% |
| Verition Fund Management LLC | 140,000 | $93,800 | 0.00% |
| DRW Securities, LLC | 37,000 | $25 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $6,700 | 0.00% |
| HUNTINGTON NATIONAL BANK | 57 | $38 | 0.00% |